Literature DB >> 16264157

Parvovirus B19 and onset of juvenile dermatomyositis.

Gulnara Mamyrova, Lisa G Rider, Laura Haagenson, Susan Wong, Kevin E Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16264157     DOI： 10.1001/jama.294.17.2170

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  13 in total

Review 1.  Risk factors and disease mechanisms in myositis.

Authors:  Frederick W Miller; Janine A Lamb; Jens Schmidt; Kanneboyina Nagaraju
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

Review 2.  Juvenile dermatomyositis update.

Authors:  Carol B Lindsley
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.592

Review 3.  The heterogeneity of juvenile myositis.

Authors:  Lisa G Rider
Journal:  Autoimmun Rev       Date:  2006-09-05       Impact factor: 9.754

Review 4.  Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.

Authors:  Adam M Huber
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 5.  Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.

Authors:  Lucy R Wedderburn; Lisa G Rider
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-10       Impact factor: 4.098

Review 6.  Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.

Authors:  Ilaria Pagnini; Antonio Vitale; Carlo Selmi; Rolando Cimaz; Luca Cantarini
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 10.817

7.  Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis.

Authors:  Shanmuganathan Chandrakasan; Surjit Singh; R K Ratho; Sharat Kumar; B Mishra
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 3.580

8.  Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; Lan Wu; Gulnara Mamyrova; Ira N Targoff; Frederick W Miller
Journal:  Rheumatology (Oxford)       Date:  2010-08-27       Impact factor: 7.580

Review 9.  Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?

Authors:  Sarah L Tansley; Neil J McHugh; Lucy R Wedderburn
Journal:  Arthritis Res Ther       Date:  2013-04-08       Impact factor: 5.156

10.  Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection.

Authors:  Giuseppe Musumeci; Paola Castrogiovanni; Ignazio Barbagallo; Daniele Tibullo; Cristina Sanfilippo; Giuseppe Nunnari; Giovanni Francesco Pellicanò; Piero Pavone; Rosario Caltabiano; Roberto Di Marco; Rosa Imbesi; Michelino Di Rosa
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.